Table 12.
Stability testing conditions | Sampling interval (months) |
Physical appearance | % Drug content of NS based gel formulation* |
---|---|---|---|
25 °C /60 ± 5% RH | 0 | No change | 91.87 ± 0.32 |
3 | No change | 90.18 ± 0.21 | |
6 | No change | 89.21 ± 0.35 | |
30 °C /60 ± 5% RH | 0 | No change | 91.87 ± 0.32 |
3 | No change | 89.67 ± 0.52 | |
6 | No change | 88.75 ± 0.28 | |
40 °C /75 ± 5% RH | 0 | No change | 91.87 ± 0.32 |
3 | No change | 88.92 ± 0.64 | |
6 | No change | 88.11 ± 0.52 |
*Mean ± SD, n = 3